A Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Selected Surgeries

Key Inclusion Criteria: * Body mass index (BMI) of greater than or equal to (≥) 18.0 to less than or equal to (≤) 40.0 kilogram per meter square (kg/m\^2) * Scheduled to undergo a procedure that is in one of the following categories that would typically be treated with opioid therapy for at least 72 hours postoperatively such as * Laparoscopic intraperitoneal or retroperitoneal procedure * Arthroscopic orthopedic procedure Key Exclusion Criteria: -Participated in previous study with Suzetrigine or received Journavx Other protocol defined Inclusion/Exclusion criteria will apply.